(Q52012290)

19 April 2018

title

Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants. (English)

1 reference

19 April 2018

2

Ray Borrow

1 reference

19 April 2018

6

Nick Andrews

1 reference

19 April 2018

Elizabeth Miller

7

object named as

Elizabeth Miller

1 reference

19 April 2018

David Goldblatt

object named as

David Goldblatt

3

1 reference

ORCID Public Data File 2021

author name string

Emma Longworth

1

1 reference

19 April 2018

Paul Balmer

4

1 reference

19 April 2018

Maureen Dawson

5

1 reference

19 April 2018

Keith Cartwright

8

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 June 2002

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

20

1 reference

19 April 2018

issue

19-20

1 reference

19 April 2018

page(s)

2592-2596

1 reference

19 April 2018

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

Production of low-avidity antibody by infants after infection with serogroup B meningococci

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900151-2

7 January 2021

10.1016/S0264-410X(02)00151-2

Identifiers

DOI

1 reference

19 April 2018

release_dfndgbxzazf35bxqutnq3mts6e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dfndgbxzazf35bxqutnq3mts6e

24 November 2022

mapped directly with Wikidata item

1 reference

19 April 2018